Microbial Bioactives

Microbial Bioactives | Online ISSN 2209-2161
380
Citations
243.9k
Views
182
Articles
Your new experience awaits. Try the new design now and help us make it even better
Switch to the new experience
REVIEWS   (Open Access)

Ergot Alkaloid Biosynthesis Across Fungal Lineages: Evolutionary Genomics, Metabolic Diversity, and Emerging Biotechnological Opportunities

Abstract 1. Introduction 2. Materials and Methods 3. Results 4. Discussion 5. Limitations 6. Conclusion References

Kamran Ashraf1,*, Wasim Ahmad2

+ Author Affiliations

Microbial Bioactives 8 (1) 1-12 https://doi.org/10.25163/microbbioacts.8110651

Submitted: 21 January 2025 Revised: 12 March 2025  Accepted: 24 March 2025  Published: 26 March 2025 


Abstract

Abstract

Ergot alkaloids occupy a rather unusual position in fungal biology. Historically, they were feared because of their association with ergotism and mass poisoning events, yet over time they have also become indispensable in medicine, agriculture, and biotechnology. This systematic review synthesizes current evidence on the biosynthesis, evolutionary diversification, and ecological significance of ergot alkaloids across major fungal lineages. Using PRISMA-guided methodologies, studies involving comparative genomics, biosynthetic pathways, and ergot alkaloid synthesis (EAS) gene clusters were systematically evaluated to examine how cluster organization influences metabolite diversity and fungal adaptation. The findings suggest that ergot alkaloid pathways are built upon a remarkably conserved biosynthetic core, although substantial variation exists in cluster size, accessory genes, and metabolic outcomes among taxa. Expanded EAS clusters in Claviceps purpurea and Epichloë festucae were strongly associated with the production of structurally complex peptide alkaloids, whereas reduced clusters in Aspergillus and Arthrodermataceae species appeared linked to simpler clavine derivatives or pathway intermediates. Meta-analytical assessments further indicated moderate heterogeneity but consistent evolutionary trends toward biosynthetic specialization in plant-associated fungi. Beyond evolutionary insights, the review highlights growing opportunities for synthetic biology, enzyme engineering, and pharmaceutical exploitation of ergot alkaloid pathways. Altogether, the study reframes ergot alkaloids not simply as toxic fungal metabolites, but as dynamic evolutionary innovations with enduring ecological and biomedical relevance

Keywords: Ergot alkaloids, Fungal secondary metabolism, EAS gene clusters, Comparative genomics, Ergopeptines Evolutionary biosynthesis, Fungal biotechnology

References

Ahimsa-Müller, M. A., Scott-Craig, J. S., Kohn, L. M., & Walton, J. D. (2007). Biosynthesis of the ergot alkaloid chanoclavine-I in Aspergillus fumigatus. Journal of Natural Products, 70(12), 1955–1960. https://doi.org/10.1021/np070315t

Beaulieu, W. T., Panaccione, D. G., & Hazen, T. C. (2013). Role of ergot alkaloids in plant–fungal interactions. Journal of Chemical Ecology, 39(7), 919–930. https://doi.org/10.1007/s10886-013-0315-z

Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2009). Introduction to meta-analysis. Wiley. https://doi.org/10.1002/9780470743386

Coyle, C. M., & Panaccione, D. G. (2005). An ergot alkaloid biosynthesis gene cluster in Aspergillus fumigatus. Applied and Environmental Microbiology, 71(6), 3112–3118. https://doi.org/10.1128/AEM.71.6.3112-3118.2005

DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7(3), 177–188. https://doi.org/10.1016/0197-2456(86)90046-2

Egger, M., Davey Smith, G., Schneider, M., & Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315(7109), 629–634. https://doi.org/10.1136/bmj.315.7109.629

Fleetwood, D. J., Scott, B., Lane, G. A., Tanaka, A., & Johnson, R. D. (2007). A complex ergovaline gene cluster in the fungal endophyte Epichloë festucae. Applied and Environmental Microbiology, 73(8), 2571–2579.

Floss, H. G. (1976). Biosynthesis of ergot alkaloids. Tetrahedron, 32(8), 873–912. https://doi.org/10.1016/0040-4020(76)85047-8

Gao, Q., Jin, K., Ying, S. H., Zhang, Y., Xiao, G., Shang, Y., Duan, Z., Hu, X., Xie, X. Q., Zhou, G., Peng, G., Luo, Z., Hu, C., Li, Y., Zhang, W., Zhang, J., Zou, G., Fang, W., & Wang, C. (2011). Genome sequencing and comparative analysis of Aspergillus fumigatus. PLoS Genetics, 7(1), e1001264. https://doi.org/10.1371/journal.pgen.1001264

Gebler, J. C., & Poulter, C. D. (1992). Prenyltransferase reactions in alkaloid biosynthesis. Archives of Biochemistry and Biophysics, 296(1), 308–313. https://doi.org/10.1016/0003-9861(92)90578-I

Gerhards, N., Neubauer, L., Tudzynski, P., & Li, S.-M. (2014). Biosynthetic pathways of ergot alkaloids. Toxins, 6(12), 3281–3295. https://doi.org/10.3390/toxins6123281             

Gröger, D., & Floss, H. G. (1998). Biochemistry of ergot alkaloids—Achievements and challenges. The Alkaloids, 50, 171–218.  https://doi.org/10.1016/S1099-4831(08)60043-7

Haarmann, T., Unsöld, I., Li, S. M., Nicholson, G. J., & Tudzynski, P. (2009). Ergot alkaloid biosynthesis genes and plant–fungus interactions. Molecular Plant Pathology, 10(4), 563–577. https://doi.org/10.1111/j.1364-3703.2009.00548.x

Haarmann, T., Weidner, A., Unsöld, I., Li, S. M., & Nicholson, G. J. (2005). Role of cytochrome P450 monooxygenases in ergot alkaloid biosynthesis. Phytochemistry, 66(11), 1312–1320. https://doi.org/10.1016/j.phytochem.2005.04.011

Higgins, J. P. T., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M. J., & Welch, V. A. (2022). Cochrane handbook for systematic reviews of interventions (Version 6.3). Cochrane. http://www.training.cochrane.org/handbook

Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003). Measuring inconsistency in meta-analyses. BMJ, 327(7414), 557–560. https://doi.org/10.1136/bmj.327.7414.557

Hulvova, H., Vaclavikova, M., & Horska, K. (2013). Ergot alkaloids: Chemistry, biosynthesis and biological effects. Biotechnology Advances, 31(1), 79–89. https://doi.org/10.1016/j.biotechadv.2012.01.005

Jakubczyk, D., Molnar, I., & Süssmuth, R. D. (2014). Biosynthetic pathways of fungal indole alkaloids. Natural Product Reports, 31(10), 1328–1338. https://doi.org/10.1039/C4NP00062E

Kozlovsky, A. G., Tudzynski, P., & Smetanska, I. (2011). Alkaloid production by endophytic fungi. Applied Biochemistry and Microbiology, 47(4), 426–430. https://doi.org/10.1134/S0003683811040065

Li, S. M., & Unsöld, I. A. (2006). Prenyltransferases in fungal secondary metabolism. Planta Medica, 72(12), 1117–1120. https://doi.org/10.1055/s-2006-947230

Lorenz, N., Boland, S., & Li, S. M. (2007). Functional characterization of ergot alkaloid biosynthesis genes. Applied and Environmental Microbiology, 73(22), 7185–7191. https://doi.org/10.1128/AEM.01412-07

Lorenz, N., Boland, S., & Li, S. M. (2009). Structural diversity of ergot alkaloids. Phytochemistry, 70(15–16), 1822–1932. https://doi.org/10.1016/j.phytochem.2009.08.019

Markert, A., Heinekamp, T., & Brakhage, A. A. (2008). Regulation of fungal secondary metabolite gene clusters. Plant Physiology, 147(1), 296–305. https://doi.org/10.1104/pp.108.116699

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71.  https://doi.org/10.1136/bmj.n71          

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., et al. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71

Panaccione, D. G., & Coyle, C. M. (2005). Ergot alkaloid biosynthesis in fungi. Applied and Environmental Microbiology, 71(6), 3106–3111. https://doi.org/10.1128/AEM.71.6.3106-3111.2005

Schardl, C. L., Pan, J., & Nagabhyru, P. (2013). Plant–fungal symbioses and alkaloid production. Toxins, 5(6), 1064–1088. https://doi.org/10.3390/toxins5061064

Schardl, C. L., Young, C. A., Hesse, U., Amyotte, S. G., Andreeva, K., Calie, P. J., Fleetwood, D. J., Haws, D. C., Moore, N., Oeser, B., Pan, J., & Charlton, N. D. (2006). Ergot alkaloids: Biology and molecular genetics. The Alkaloids, 63, 45–86. https://doi.org/10.1016/S1099-4831(06)63002-2

Schiff, P. L. (2006). Ergot alkaloids: Historical and medicinal perspectives. American Journal of Pharmaceutical Education, 70(5), 1–10. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1637017/

Tsai, H. F., Yu, J. H., & Chang, Y. C. (1995). Cloning and analysis of ergot alkaloid biosynthetic genes. Biochemical and Biophysical Research Communications, 216(1), 119–125. https://doi.org/10.1006/bbrc.1995.2599

Tudzynski, P., Li, S. M., & Unsöld, I. (1999). Molecular genetics of ergot alkaloid biosynthesis. Molecular and General Genetics, 261(1), 133–141. https://doi.org/10.1007/s004380050950

Unsöld, I. A. (2006). Prenylated indole alkaloids from fungi (Doctoral dissertation). Universität Tübingen.

Unsöld, I. A., & Li, S. M. (2005). Reverse prenyltransferases in fungal metabolism. Microbiology, 151(5), 1499–1505. https://doi.org/10.1099/mic.0.27750-0

Wallwey, C., & Li, S. M. (2011). Ergot alkaloids: Structure, biosynthesis and biological activity. Natural Product Reports, 28(3), 496–510. https://doi.org/10.1039/C0NP00060D

Williams, R. M., Glinka, T., & Frolov, A. (2000). Biosynthesis of complex indole alkaloids. Topics in Current Chemistry, 209, 97–173. https://doi.org/10.1007/3-540-48146-X_4


Article metrics
View details
2
Downloads
0
Citations
355
Views
📖 Cite article

View Dimensions


View Plumx


View Altmetric



2
Save
0
Citation
355
View
0
Share